As a result, the combination of antibiotics, that usually interfere with key events in pathogen replication, with bactericidal agents (e.g., AMPs), that directly attack bacterial structures such as the membrane, and finally with immunomodulatory agents, comprised in distinctive patterns of MSC-derived EVs, emerges as the leading strategy to counteract chronic and severe bacterial infections. This evidence concerns the gene ADSL and bacterial infectious disease.